
A study published in Nature Communications reveals that rare genetic mutations and common DNA variants interact to significantly increase the risk of early-onset atrial fibrillation.
Analysis of the U.K. Biobank, involving over 500,000 participants, showed that individuals with a high burden of common genetic risk variants face approximately twice the risk of developing the condition.
Researchers identified that mutations in the LMNA gene alter DNA packaging, affecting heart cell electrical signals and providing a concrete example of how additive genetic risk influences heart health.